CONCERT PHARMACEUTICALS, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2013 to Q3 2022

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Concert Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2013 to Q3 2022.
  • Concert Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2022 was 49.7M shares, a 45.9% increase year-over-year.
  • Concert Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 34.4M shares, a 10.3% increase from 2020.
  • Concert Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 31.2M shares.
  • Concert Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2018 was 23.4M shares, a 3.22% increase from 2017.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 49.7M +15.6M +45.9% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 41M +7.07M +20.8% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 36.7M +2.79M +8.24% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 34.4M Oct 1, 2021 Dec 31, 2021 10-K 2022-03-03
Q3 2021 34.1M +2.54M +8.06% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 34M +2.52M +8.01% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 33.9M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 31.5M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 31.5M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q4 2018 23.4M +729K +3.22% Oct 1, 2018 Dec 31, 2018 10-K 2019-02-28
Q3 2018 23.4M +727K +3.2% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-01
Q2 2018 23.4M +823K +3.65% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-02
Q1 2018 23.2M +846K +3.78% Jan 1, 2018 Mar 31, 2018 10-Q 2018-05-03
Q4 2017 22.6M +408K +1.84% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 22.7M +465K +2.09% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 22.6M +362K +1.63% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-02
Q1 2017 22.4M +179K +0.81% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-03
Q4 2016 22.2M +1.08M +5.11% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 22.2M +280K +1.28% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 22.2M +455K +2.09% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 22.2M +3.47M +18.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-02
Q4 2015 21.2M +5.31M +33.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 21.9M +3.85M +21.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 21.8M +3.83M +21.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 18.7M +9.54M +104% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 15.8M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-06
Q3 2014 18.1M Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 17.9M +16.6M +1290% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 9.19M +7.9M +612% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-14
Q2 2013 1.29M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 1.29M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.